Role of terlipressin in the treatment of infants and neonates with catecholamine-resistant septic shock

Best Practice and Research: Clinical Anaesthesiology

Volumn 22, Issue 2, 2008, Pages 323-333

  Leone, Marc ^a   Martin, Claude ^a  

^a HÔPITAL NORD   (France)

Author keywords

paediatrics; septic shock; terlipressin

Indexed keywords

ADRENALIN; ARGIPRESSIN; CATECHOLAMINE; NORADRENALIN; OXYTOCIN; TERLIPRESSIN; VASOPRESSIN;

BRADYCARDIA; CHILD CARE; CHILDHOOD MORTALITY; CLINICAL TRIAL; CONTINUOUS INFUSION; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HALF LIFE; DRUG INTERMITTENT THERAPY; DRUG MECHANISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG USE; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; HEART ARREST; HEART PERFORMANCE; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPOTENSION; LOW DRUG DOSE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK; SIDE EFFECT; SINGLE DRUG DOSE; SKIN BLOOD VESSEL DISORDER; SKIN NECROSIS; VASOCONSTRICTION;

ANIMALS; CATECHOLAMINES; DRUG RESISTANCE; HUMANS; INFANT; INFANT, NEWBORN; LYSINE VASOPRESSIN; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 44949200030     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpa.2008.02.008     Document Type: Review

References (56)

1. Bauer P.R. Microvascular responses to sepsis: clinical significance. Pathophysiology 8 (2002) 141-148
2. Sladen R.N., and Landry D. Renal blood flow regulation, autoregulation, and vasomotor nephropathy. Anesthesiology Clinics of North America 18 (2000) 791-807
3. Takakura K., Taniguchi T., Muramatsu I., et al. Modification of alpha 1-adrenoreceptors by peroxynitrite as a possible mechanism of systemic hypotension in sepsis. Critical Care Medicine 30 (2002) 894-899
4. Delmas A., Leone M., Rousseau S., et al. Vasopressin and terlipressin in septic shock patients. Critical Care 9 (2004) 212-222
5. Barrett L.K., Singer M., and Clapp L.H. Vasopressin mechanisms of action on the vasculature in health and in septic shock. Critical Care Medicine 35 (2007) 310-312
6. Oliver H., and Shafer E. On the physiological action of extracts of the pituitary body and certain other glandular organs. The Journal of Physiology (London) 18 (1895) 277-279
7. Laszlo F.A., Laszlo Jr. F., and De Wield D. Pharmacology and clinical perspectives of vasopressin antagonists. Pharmacological Reviews 43 (1991) 73-108
8. Landry D.W., Levin H.R., Gallant E.M., et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95 (1997) 1122-1125
9. Barberis C., Mouillac B., and Durroux T. Structural bases of vasopressin/oxytocin receptor function. The Jouranl of Endocrinology 156 (1998) 223-229
10. Olmes C.L., Patel B.M., and Russell J.A. Physiology of vasopressin relevant to management of septic shock. Chest 120 (2001) 989-999
11. Sklar A.H., and Schrier R.W. Central nervous system mediators of vasopressin release. Physiological Reviews 63 (1983) 1243-1280
12. Patel B.M., Chittock D.R., Russell J.A., and Walley K.R. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96 (2002) 576-582
13. Sharshar T., Carlier R., Blanchard A., et al. Depletion of neurohypophy-seal content of vasopressin in septic shock. Critical Care Medicine 30 (2002) 497-500
14. Sharshar T., Blanchard A., Paillard M., et al. Circulating vasopressin levels in septic shock. Critical Care Medicine 31 (2003) 1752-1758
15. Day T.A., Randle J.C., and Renaud L.P. Opposing α- and β-adrenergic mechanisms mediate dose-dependent actions of norepinephrine on supraoptic vasopressin neurones in vivo. Brain Research 358 (1985) 171-179
16. Bucher M., Hobbhahn J., and Kurtz A. Cytokine-mediated downregulation of vasopressin V1a receptors during acute endotoxemia in rats. American Journal of Physiology 282 (2002) R979-R984
17. Leone M., and Boyle W.A. Decreased vasopressin responsiveness in vasodilatory septic shock-like conditions. Critical Care Medicine 34 (2006) 1126-1130
18. Segarra G., Medina P., Vila J.M., et al. Increased contraction to noradrenaline by vasopressin in human renal arteries. Journal of Hypertension 20 (2002) 1373-1379
19. Barret L.K., Orie N.N., Taylor V., et al. Differential effects of vasopressin and norepinephrine on vascular reactivity in a long-term rodent model of sepsis. Critical Care Medicine 35 (2007) 2337-2343
20. Hollenberg S.M., Tangora J.J., Piotrowski M.J., et al. Impaired microvascular vasoconstrictive responses to vasopressin in septic rats. Critical Care Medicine 25 (1997) 869-873
21. Malay M.B., Ashton Jr. R.C., Landry D.W., and Townsend R.N. Low-dose vasopressin in the treatment of vasodilatory septic shock. The Journal of Trauma 47 (1999) 699-703
22. Tsuneyoshi I., Yamada H., Kakihana Y., et al. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Critical Care Medicine 29 (2001) 487-493
23. Holmes C.L., Walley K.R., Chittock D.R., et al. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Medicine 27 (2001) 1416-1421
24. Dunser M.W., Mayr A.J., Ulmer H., et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 107 (2003) 2313-2319
25. Obritsch M.D., Jung R., Fish D.N., and MacLaren R. Effects of continuous vasopressin infusion in patients with septic shock. Annals of Pharmacotherapy 38 (2004) 1117-1122
26. Hall L.G., Oyen L.J., Taner C.B., et al. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock. Pharmacotherapy 24 (2004) 1002-1012
27. Klinzing S., Simon M., Reinhart K., et al. High-dose vasopressin is not superior to norepinephrine in septic shock. Critical Care Medicine 31 (2003) 2646-2650
28. Luckner G., Mayr V.D., Jochberger S., et al. Comparison of two dose regimens of arginine vaopressin in advanced dilatory shock. Critical Care Medicine 35 (2007) 2280-2285
29. O'Brien A., Clapp L., and Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet 359 (2002) 1209-1210
30. Leone M., Albanese J., Delmas A., et al. Terlipressin in catecholamine-resistant septic shock patients. Shock 22 (2004) 314-319
31. Morelli A., Rocco M., Conti G., et al. Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock. Intensive Care Medicine 30 (2004) 597-604
32. Albanèse J., Leone M., Delmas A., and Martin C. Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study. Critical Care Medicine 33 (2005) 1897-1902
33. Pesaturo A.B., Jennings H.R., and Voils S.A. Terlipressin: vasopressin analog and novel drug for septic shock. Annals of Pharmacotherapy 40 (2006) 2170-2177
34. Asfar P. Terlipressin in chronic hyperdynamic endotoxic shock: is it safe?. Intensive Care Medicine 29 (2003) 154-155
35. Nilsson G., Lindblom P., Ohlin M., et al. Pharmacokinetics of terlipressin after single i.v. doses to healthy volunteers. Drugs under Experimental and Clinical Research 16 (1990) 307-314
36. Scharte M., Meyer J., VanAken H., and Bone H.G. Hemodynamic effects of terlipressin (a synthetic analog of vasopressin) in healthy and endotoxemic sheep. Critical Care Medicine 29 (2001) 1756-1760
37. Westphal M., Stubbe H., Sielenkamper A.W., et al. Terlirpessin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport. Intensive Care Medicine 29 (2003) 301-308
38. Asfar P., Pierrot M., Veal N., et al. Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats. Critical Care Medicine 31 (2003) 215-220
39. Asfar P., Hauser B., Ivanyi Z., et al. Low-dose terlipressin during long-term hyperdynamic porcine endotoxemia: effects on hepatosplanchnic perfusion, oxygen exchange, and metabolism. Critical Care Medicine 33 (2005) 373-380
40. Lange M., Morelli A., Ertmer C., et al. Continuous versus bolus infusion of terlipressin in ovine endotoxemia. Shock 28 (2007) 623-629
41. Donato A.J., Lesniewski L.A., and Delp M.D. Ageing and exercise training alter adrenergic vasomotor responses of rat skeletal muscle arterioles. The Journal of Physiology 579 Pt 1 (2007) 115-125
42. Delp M.D., Brown M., Laughlin M.H., and Hasser E.M. Rat aortic vasoreactivity is altered by old age and hindlimb unloading. Journal of Applied Physiology 78 (1995) 2079-2086
43. Sarthi M., Lodha R., Vivekanandhan S., and Arora N.K. Adrenal status in children with septic shock using low-dose stimulation test. Pediatric Critical Care Medicine 8 (2007) 23-28
44. Leclerc F., Walter-Nicolet E., Leteurtre S., et al. Admission plasma vasopressin levels in children with meningococcal septic shock. Intensive Care Medicine 29 (2003) 1339-1344
45. Lodha R., Vivekanandhan S., Sarthi M., and Kabra S.K. Serial circulating vasopressin levels in children with septic shock. Pediatric Critical Care Medicine 7 (2006) 220-224
46. Debray D., Yousef N., and Durand P. New management options for end-stage chronic liver disease and acute liver failure: potential for pediatric patients. Paediatric Drugs 8 (2006) 1-13
47. Matok I., Vardi A., Augarten A., et al. Beneficial effects of terlipressin in prolonged pediatric cardiopulmonary resuscitation: a case series. Critical Care Medicine 35 (2007) 1161-1164
48. Rodríguez-Núñez A., Fernández-Sanmartín M., Martinón-Torres F., et al. Terlipressin for catecholamine-resistant septic shock in children. Intensive Care Medicine 30 (2004) 477-480
49. Peters M.J., Booth R.A., and Petros A.J. Terlipressin bolus induces systemic vasoconstriction in septic shock. Pediatric Critical Care Medicine 5 (2004) 112-115
50. Matok I., Leibovitch L., Vardi A., et al. Terlipressin as rescue therapy for intractable hypotension during neonatal septic shock. Pediatric Critical Care Medicine 5 (2004) 116-118
51. Matok I., Vard A., Efrati O., et al. Terlipressin as rescue therapy for intractable hypotension due to septic shock in children. Shock 23 (2005) 305-310
52. Zeballos G., López-Herce J., Fernández C., et al. Rescue therapy with terlipressin by continuous infusion in a child with catecholamine-resistant septic shock. Resuscitation 68 (2006) 151-153
53. Rodríguez-Núñez A., López-Herce J., Gil-Antón J., et al. Rescue treatment with terlipressin in children with refractory septic shock: a clinical study. Critical Care 10 (2006) R20
54. Michel F., Thomachot L., David M., et al. Continuous low-dose infusion of terlipressin as a rescue therapy in meningococcal septic shock. American Journal of Emergency Medicine 25 (2007) 863
55. Papoff P., Mancuso M., Barbara C.S., and Moretti C. The role of terlipressin in pediatric septic shock: a review of the literature and personal experience. International Journal of Immunopathology and Pharmacology 20 (2007) 213-221
56. Dünser M.W., Mayr A.J., Tür A., et al. Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors. Critical Care Medicine 31 (2003) 1394-1398